TABLE 3.

Sterol quantification expressed as a percentage of the cell dry weighta

GroupbStrainMean % concn ± SDP
NTFLCAMDFLC-AMDFLC vs NTAMD vs NTFLC-AMD vs NTFLC+AMD vs FLCFLC-AMD vs AMD
I360820.45 ± 0.050.11 ± 0.010.60 ± 0.010.70 ± 0.050.00960.320.0710.00010.05
I53140.70 ± 0.050.40 ± 0.030.80 ± 0.010.70 ± 0.010.00890.730.820.0151.00
II900281.30 ± 0.020.60 ± 0.031.20 ± 0.020.50 ± 0.030.00010.270.00010.580.0003
III10021.25 ± 0.010.30 ± 0.001.15 ± 0.000.50 ± 0.000.00010.050.00010.00010.0001
III37951.05 ± 0.050.75 ± 0.010.85 ± 0.050.40 ± 0.020.0170.150.00080.00160.005
IV6101.75 ± 0.051.1 ± 0.021.45 ± 0.000.8 ± 0.020.00050.0170.00010.00440.0001
IV6111.45 ± 0.000.7 ± 0.051.35 ± 0.000.6 ± 0.020.00010.050.00010.580.0001
  • a NT, no treatment.

  • b Groups I and II, control laboratory strains; group III, clinical isogenic strains; group IV, clinical isogenic strains; group I, massive filamentous form production; groups II, III, and IV, regular pseudohypha and true hypha production.